Trademark: 90293047
Status Date
Monday, August 14, 2023
Filing Date
Monday, November 2, 2020
Published for Opposition
Tuesday, May 18, 2021
Abandoned Date
Monday, August 14, 2023
5 Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapy preparations; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Aug 14, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 14, 2023
Abandonment - No Use Statement Filed
Jan 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2023
Sou Extension 3 Granted
Jan 13, 2023
Sou Extension 3 Filed
Jan 13, 2023
Sou Teas Extension Received
Jul 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2022
Sou Extension 2 Granted
Jul 12, 2022
Sou Extension 2 Filed
Jul 12, 2022
Sou Teas Extension Received
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2022
Sou Extension 1 Granted
Jan 13, 2022
Sou Extension 1 Filed
Jan 13, 2022
Sou Teas Extension Received
Jul 13, 2021
Noa E-Mailed - Sou Required From Applicant
May 18, 2021
Official Gazette Publication Confirmation E-Mailed
May 18, 2021
Published For Opposition
Apr 28, 2021
Notification Of Notice Of Publication E-Mailed
Apr 8, 2021
Approved For Pub - Principal Register
Apr 8, 2021
Examiner's Amendment Entered
Apr 8, 2021
Notification Of Examiners Amendment E-Mailed
Apr 8, 2021
Examiners Amendment E-Mailed
Apr 8, 2021
Examiners Amendment -Written
Apr 6, 2021
Assigned To Examiner
Dec 28, 2020
New Application Office Supplied Data Entered
Nov 5, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
